Skip to main content
Log in

Psychiatric Disorders in Prader-Willi Syndrome

Epidemiology and Management

  • Therapy In Practice
  • Published:
CNS Drugs Aims and scope Submit manuscript

Abstract

Although people with intellectual disabilities are at increased risk for psychiatric disorders, the type and rate of these problems differ between those with different causes for their retardation. In this paper, we review behavioural and psychiatric problems in persons with Prader-Willi syndrome, a disorder caused by a paternally derived deletion at chromosome 15(q11-q13) in about 70% of affected patients, and by maternal uniparental disomy in the majority of the remaining patients.

In addition to the syndrome’s characteristic hyperphagia and food seeking, individuals with Prader-Willi syndrome also have increased risks of nonfood, compulsive behaviours. These include skin picking, which is highly prevalent, as well as more variable rates of hoarding, redoing and concerns with symmetry, exactness, cleanliness, ordering and arranging. Relative to others with mental retardation, persons with Prader-Willi syndrome are at a marked increased risk for developing full-blown, obsessive-compulsive disorder. In addition, many people with Prader-Willi syndrome show increased rates of tantrums, oppositionality and aggression. Recent findings suggest that they also have an increased risk of psychotic disorder or affective illness with a psychotic component, especially young adult patients and those with the maternal uniparental disomy as opposed to paternal deletion.

Dietary approaches include a reduced-calorie diet and increased physical activity, as well as close supervision around food and keeping food locked away. To date, neither CNS stimulants nor anorectic agents have been effective in treating hyperphagia, in part because hyperphagia in Prader-Willi syndrome is attributed to decreased satiation as opposed to increased hunger.

Treatment for compulsivity and maladaptive behaviours include: behavioural programming; a structured, predictable routine; extra help with transitions; family support; and pharmacotherapy.

Although formal drug studies have yet to be conducted, SSRIs have been effective in reducing skin picking, compulsivity and aggressive episodes in some individuals with Prader-Willi syndrome. Atypical antipsychotics have also proven helpful in persons with psychotic features or extreme aggression and impulsivity. Largely on the basis of case studies, the risks and benefits of these and other drugs in Prader-Willi syndrome are reviewed. Drug trials that move beyond case studies and that assess the relative efficacy of behavioural treatments alone or in combination with pharmacotherapy are sorely needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Similar content being viewed by others

References

  1. Prader A, Labhart A, Willi A. Ein syndrom von aidositas, kleinwuchs, kryptorchismus und oligophrenie nach myotonieartigem zustand im neugeborenenalter. Schweiz Med Wochenschr 1956; 86: 1260–1

    Google Scholar 

  2. Ledbetter DH, Riccardi VM, Airhart SD, et al. Deletion of chromosome 15 as a cause of Prader-Willi syndrome. N Engl J Med 1981; 304: 325–9

    Article  PubMed  CAS  Google Scholar 

  3. Butler MG, Meaney FJ, Palmer CG. Clinical and cytogenetic survey of 39 individuals with Prader-Labhart-Willi syndrome. Am J Med Genet 1986; 23: 793–809

    Article  PubMed  CAS  Google Scholar 

  4. Nicholls RD. Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndrome: a review. Am J Med Genet 1993; 46: 16–25

    Article  PubMed  CAS  Google Scholar 

  5. Whittington JE, Holland AJ, Webb T, et al. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet 2001; 38: 792–8

    Article  PubMed  CAS  Google Scholar 

  6. Dykens EM, Hodapp RM, Finucane BM. Genetics and mental retardation syndromes: a new look at behavior and interventions. Baltimore (MD): Brookes, 2000

    Google Scholar 

  7. Curfs LMG. Psychological profile and behavioral characteristics in Prader-Willi syndrome. In: Cassidy SB, editor. Prader-Willi syndrome and other 15q deletion disorders. Berlin: Springer-Verlag, 1992: 211–22

    Google Scholar 

  8. Dykens EM, Hodapp RM, Walsh KK, et al. Profiles, correlates, and trajectories of intelligence in Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry 1992; 31: 1125–30

    Article  PubMed  CAS  Google Scholar 

  9. Curfs LG, Wiegers AM, Sommers JR, et al. Strengths and weaknesses in the cognitive profile of youngsters with Prader-Willi syndrome. Clin Genet 1991; 40: 430–4

    Article  PubMed  CAS  Google Scholar 

  10. Dykens EM, Hodapp RM, Walsh K, et al. Adaptive and maladaptive behavior in Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry 1992; 31: 1131–6

    Article  PubMed  CAS  Google Scholar 

  11. Dykens EM. Are jigsaw puzzle skills “spared” in persons with Prader-Willi syndrome? J Child Psychol Psychiatry 2002; 43: 343–52

    Article  PubMed  Google Scholar 

  12. Dykens EM, Cassidy SB, King BH. Maladaptive behavior differences in Prader-Willi syndrome due to paternal deletion versus maternal uniparental disomy. Am J Ment Retard 1999; 104: 67–77

    Article  PubMed  CAS  Google Scholar 

  13. Roof E, Stone W, MacLean W, et al. Intellectual characteristics of Prader-Willi syndrome: comparison of genetic subtypes. J Intellect Disabil Res 2000; 44: 25–30

    Article  PubMed  Google Scholar 

  14. Dykens EM, Cassidy SB. Correlates of maladaptive behavior in children and adults with Prader-Willi syndrome. Am J Med Genet 1995; 60: 546–9

    Article  PubMed  CAS  Google Scholar 

  15. Clarke DJ, Boer H, Chung MC, et al. Maladaptive behaviour in Prader-Willi syndrome in adult life. J Intellect Disabil Res 1996; 40: 159–65

    Article  PubMed  Google Scholar 

  16. Dykens EM, Kasari C. Maladaptive behavior in children with Prader-Willi syndrome, Down syndrome, and non-specific mental retardation. Am J Ment Retard 1997; 102: 228–37

    Article  PubMed  CAS  Google Scholar 

  17. Holm VA, Cassidy SB, Butler MG, et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993; 91: 398–402

    PubMed  CAS  Google Scholar 

  18. Achenbach TM. Manual for the Child Behavior Checklist. Burlington (VA): University of Vermont, Department of Psychiatry, 1999

  19. Dykens EM, Cassidy SB. Prader-Willi syndrome. In: Goldstein S, Reynolds CR, editors. Handbook of neurobehavioral and genetic disorders in children. New York: Guilford Press, 1999: 525–54

    Google Scholar 

  20. Dykens EM, Leckman JF, Cassidy SB. Obsessions and compulsions in Prader-Willi syndrome. J Child Psychol Psychiatry 1996; 37: 995–1002

    Article  PubMed  CAS  Google Scholar 

  21. Dykens EM. Psychopathology in children with intellectual disability. J Child Psychol Psychiatry 2001; 41: 407–17

    Article  Google Scholar 

  22. Vitiello B, Spreat S, Behar D. Obsessive-compulsive disorder in mentally retarded patients. J Nerv Ment Dis 1989; 177: 232–6

    Article  PubMed  CAS  Google Scholar 

  23. Dimitropoulos A, Feurer I, Butler MG, et al. Emergence of compulsive behavior and tantrums in children with Prader Willi syndrome. Am J Ment Retard 2001; 106: 39–51

    Article  PubMed  CAS  Google Scholar 

  24. Symons FJ, Butler MG, Sanders MD, et al. Self-injurious behavior and Prader-Willi syndrome: behavioral forms and body locations. Am J Ment Retard 1999; 104: 260–9

    Article  PubMed  CAS  Google Scholar 

  25. Dykens EM, Smith ACM. Distinctiveness and correlates of maladaptive behavior in children and adolescents with Smith-Magenis syndrome. J Intellect Disabil Res 1998; 42: 481–9

    Article  PubMed  Google Scholar 

  26. State M, Dykens EM, Rosner B, et al. Obsessive-compulsive symptoms in Prader-Willi and “Prader-Willi—like” patients. J Am Acad Child Adolesc Psychiatry 1999; 38: 329–34

    Article  PubMed  CAS  Google Scholar 

  27. Cassidy SB, Devi A, Mukaida C. Aging in Prader-Willi syndrome: 22 patients over age 30 years. Proc Greenwood Genet Cent 1994; 13: 102–3

    Google Scholar 

  28. Holland AJ, Treasure J, Coskeran P, et al. Characteristics of the eating disorder in Prader-Willi syndrome: implications for treatment. J Intellect Disabil Res 1995; 39: 373–81

    Article  PubMed  Google Scholar 

  29. Swaab DF, Purba JS, Hofman MA. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of 5 cases. J Clin Endocrinol Metab 1995; 80: 573–9

    Article  PubMed  CAS  Google Scholar 

  30. Caldwell ML, Taylor RL. A clinical note on the food preference of individuals with Prader-Willi syndrome: the need for empirical research. J Ment Defic Res 1983; 27: 45–9

    PubMed  Google Scholar 

  31. Taylor RL, Caldwell ML. Type and strength of food preferences of individuals with Prader-Willi syndrome. Am J Ment Defic 1985; 29: 109–12

    Google Scholar 

  32. Fieldstone A, Zipf WB, Schwartz HC, et al. Food preferences in Prader-Willi syndrome, normal weight, and obese controls. Int J Obes Relat Metab Disord 1997; 21: 1–7

    Article  Google Scholar 

  33. Dykens EM. Contaminated and unusual food combinations: what do people with Prader-Willi syndrome choose? Ment Retard 2000; 38: 163–71

    Article  PubMed  CAS  Google Scholar 

  34. Beardsmore A, Dorman T, Cooper SA, et al. Affective psychosis and Prader-Willi syndrome. J Intellect Disabil Res 1998; 42: 463–71

    Article  PubMed  Google Scholar 

  35. Clarke DJ. Prader-Willi syndrome and psychoses. Br J Psychiatry 1993; 163: 680–4

    Article  PubMed  CAS  Google Scholar 

  36. Clarke DJ, Boer H, Webb T, et al. Prader-Willi syndrome and psychotic symptoms. 1: case descriptions and genetic studies. J Intellect Disabil Res 1998; 42: 440–50

    Article  Google Scholar 

  37. Clarke DJ, Webb T, Bachmann-Clarke JP. Prader-Willi syndrome and psychotic symptoms: report of a further case. Ir J Psychol Med 1995; 12: 27

    Google Scholar 

  38. Verhoeven WMA, Curfs LMG, Tuinier S. Prader-Willi syndrome and cycloid psychoses. J Intellect Disabil Res 1998; 42: 455–62

    Article  PubMed  Google Scholar 

  39. Clarke DJ. Prader-Willi syndrome and psychotic symptoms. 2: a preliminary study of prevalence using the psychopathology assessment schedule for adults with developmental disability checklist. J Intellect Disabil Res 1998; 42: 451–4

    Google Scholar 

  40. Stein DJ, Keating K, Zar HJ, et al. A survey of the phenomenology and pharmacotherapy of compulsive and impulsive-aggressive symptoms in Prader-Willi syndrome. J Neuropsychiatry Clin Neurosci 1994; 6: 23–9

    PubMed  CAS  Google Scholar 

  41. Bregman JD. Current developments in the understanding of mental retardation. Part II: psychopathology. J Am Acad Child Adolesc Psychiatry 1991; 30: 861–72

    Article  CAS  Google Scholar 

  42. Whitman BY, Accardo P. Emotional problems in Prader-Willi adolescents. Am J Med Genet 1987; 28: 897–905

    Article  PubMed  CAS  Google Scholar 

  43. Holland T, Whittington J, Webb T, et al. Findings from a population-based study of Prader-Willi syndrome. The 4th Prader-Willi Syndrome International Scientific Workshop and Conference; 2001 Jun 27–Jul 1; St. Paul

  44. Vogels A, Descheemaeker M, Govers V, et al. Long-term follow-up of children with Prader-Willi syndrome: are some Prader-Willi syndrome children more vulnerable for developing psychotic problems than others? The 4th Prader-Willi Syndrome International Scientific Workshop and Conference; 2001 Jun 27–Jul 1; St. Paul

  45. Huffa BP. One year results of growth hormone treatment of short stature in Prader-Willi syndrome. Acta Paediatr Suppl 1997; 423: 63–5

    Article  Google Scholar 

  46. Lindgren AC, Hagenas L, Muller J, et al. Effects of growth hormone treatment on growth and body composition in Prader-Willi syndrome: a preliminary report. Acta Paediatr Suppl 1997; 423: 423–62

    Google Scholar 

  47. Hodapp RM, Freeman SFN, Kasari C. Parental educational preferences for students with metal retardation: effects of etiology and current placement. Educ Train Ment Retard Develop Disabil 1998; 33: 342–9

    Google Scholar 

  48. Lindgren AC, Barkeling B, Hagg A, et al. Eating behavior in Prader-Willi syndrome, normal weight, and obese control groups. J Pediatr 2000; 137: 50–5

    Article  PubMed  CAS  Google Scholar 

  49. Itoh M, Koeda T, Ohno K, et al. Effects of mazindol in two patients with Prader-Willi syndrome. Pediatr Neurol 1995; 13(4): 349–51

    Article  PubMed  CAS  Google Scholar 

  50. Coakley JH, Moorcraft J, Hipkin LJ, et al. The effect of mazindol on growth hormone secretion in boys with Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 1988; 51: 1551–7

    Article  PubMed  CAS  Google Scholar 

  51. Weiss GF, Rogacki N, Fueg A, et al. Impact of hypothalamic d-norfenfluramine and peripheral d-fenfluramine injection on macronutrient intake in the rat. Brain Res Bull 1990; 25(6): 849–59

    Article  PubMed  CAS  Google Scholar 

  52. Selikowitz M, Sunman J, Pendergast A, et al. Fenfluramine in Prader-Willi syndrome: a double-blind, placebo-controlled trial. Arch Dis Child 1990; 65: 112–4

    Article  PubMed  CAS  Google Scholar 

  53. Fowles RE, Cloward TV, Yowell RL. Endocardial fibrosis associated with fenfluramine-phentermine [letter]. N Engl J Med 1998; 338(18): 1316

    Article  PubMed  CAS  Google Scholar 

  54. Kimmel SE, Keane MG, Crary JL, et al. Detailed examination of fenfluramine-phentermine users with valve abnormalities identified in Fargo, North Dakota. Am J Cardiol 1999; 84(3): 324–6

    Article  Google Scholar 

  55. Baumann MH, Ayestas MA, Dersch CM, et al. Serotonin transporters, serotonin release, and the mechanism of fen-fluramine neurotoxicity. Ann N Y Acad Sci 2000; 914:172–86

    Article  PubMed  CAS  Google Scholar 

  56. Akefeldt A, Ekman R, Gillberg L, et al. Cerebrospinal fluid monoamines in Prader-Willi syndrome. Biol Psychiatry 1998; 44(12): 1321–8

    Article  PubMed  CAS  Google Scholar 

  57. Dech B, Budow L. The use of fluoxetine in an adolescent with Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry 1991; 30: 298–302

    Article  PubMed  CAS  Google Scholar 

  58. Hellings JA, Warnock JK. Self-injurious behavior and serotonin in Prader-Willi syndrome. Psychopharmacol Bull 1994; 30(2): 245–50

    PubMed  CAS  Google Scholar 

  59. Benjamin E, Buot-Smith T. Naltrexone and fluoxetine in Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry 1993; 32: 870–3

    Article  PubMed  CAS  Google Scholar 

  60. Kohn Y, Weizman A, Apter A. Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine. Int J Eat Disord 2001; 30: 113–7

    Article  PubMed  CAS  Google Scholar 

  61. Berendsen HH. The role of serotonin in hot flashes. Maturitas 2000; 36: 155–64

    Article  PubMed  CAS  Google Scholar 

  62. Warnock JK, Clayton AH, Shaw HA, et al. Onset of menses in two adult patients with Prader-Willi syndrome treated with fluoxetine. Psychopharmacol Bull 1995; 31(2): 239–42

    PubMed  CAS  Google Scholar 

  63. Akefeldt A, Tornhage CJ, Gillberg C. A woman with Prader-Willi syndrome gives birth to a healthy baby girl [letter]. Dev Med Child Neurol 1999; 41: 789–90

    Article  PubMed  CAS  Google Scholar 

  64. Jerome L. Prader-Willi and bipolar illness. J Am Acad Child Adolesc Psychiatry 1993; 32(4): 876–7

    Article  PubMed  CAS  Google Scholar 

  65. Tu J-B, Hartridge C, Izawa J. Psychopharmacogenetic aspects of Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry 1992; 31: 1137–40

    Article  PubMed  CAS  Google Scholar 

  66. Gupta BK, Fish DN, Yerevanian BI. Carbamazepine for intermittent explosive disorder in a Prader-Willi syndrome patient [letter]. J Clin Psychiatry 1987; 10: 423

    Google Scholar 

  67. Shapira NA, Lessig MC, Goodman WK, et al. Open label pilot study of topiramate in adults with Prader-Willi syndrome. The 4th Prader-Willi Syndrome International Scientific Workshop and Conference; 2001 Jun 27–Jul 1; St. Paul

  68. Ebert MH, Schmidt DE, Thompson T, et al. Elevated plasma gamma-amino butyric acid (GABA) levels in individuals with either Prader-Willi syndrome or Angelman syndrome. J Neuropsychiatry Clin Neurosci 1997; 9(1): 75–80

    PubMed  CAS  Google Scholar 

  69. Pereda Bikandi M, Antizar Moro I, Querejeta Ayerdi I, et al. Psychotic disorder in Prader-Willi syndrome: a case report. Actas Esp Psiquiatr 2001; 29(3): 208–12

    PubMed  CAS  Google Scholar 

  70. Frankenburg FR. Choices in antipsychotic therapy in schizophrenia. Harv Rev Psychiatry 1999; 5: 241–9

    Article  Google Scholar 

  71. Durst R, Rubin-Jabotinski K, Raskin S, et al. Risperidone in Prader-Willi syndrome [letter]. J Am Acad Child Adolesc Psychiatry 2000; 39: 545–6

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by a grant from the National Institute of Child Health and Human Development (NICHD), Rol HD 35684. The authors are grateful for the support of the National Prader-Willi Syndrome Association and Prader-Willi California Foundation for their support of our research in general. The authors have no conflicts of interest that are directly relevant to the contents of this review.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dykens, E., Shah, B. Psychiatric Disorders in Prader-Willi Syndrome. CNS Drugs 17, 167–178 (2003). https://doi.org/10.2165/00023210-200317030-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-200317030-00003

Keywords

Navigation